Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. (Q37843732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Chih-Ching Yen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Wu-Huei Hsu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yi-Hsin Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hsin-Tang Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hsiao-Ling Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Chuan-Mu Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

16 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

585-594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327478%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10534-011-9423-8

22 January 2020

exact match

0 references

cites work

Lactoferrin as a natural immune modulator

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Selective digestive decontamination and antibiotic resistance: a balancing act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

WHO estimates of the causes of death in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Prevention of acquired infections in intubated patients with the combination of two decontamination regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Production of recombinant porcine lactoferrin exhibiting antibacterial activity in methylotrophic yeast, Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Effects of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Lactoferrin: structure, function and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Porcine lactoferrin administration enhances peripheral lymphocyte proliferation and assists infectious bursal disease vaccination in native chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Resistance patterns among nosocomial pathogens: trends over the past few years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Signaling to NF-kappaB by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia coli to host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Lactoferrin-binding proteins in Bifidobacterium bifidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Perspectives on interactions between lactoferrin and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Capsule polysaccharide is a bacterial decoy for antimicrobial peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Treatment of enterogenic endotoxinemia with lactoferrin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Effect of lactoferrin on enteroaggregative E. coli (EAEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

21 January 2018

Escherichia coli O157.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Prevention of ventilator-associated pneumonia by oral decontamination: just another SDD study?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

A component of innate immunity prevents bacterial biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Bovine lactoferrin and lactoferricin derived from milk: production and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Lactoferrin: an important host defence against microbial and viral attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Selective digestive decontamination: for everyone, everywhere?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8

Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9423-8